Wednesday’s positive data for the eczema drug tralokinumab has given Leo Pharma a pat on the back for its relatively new gamble on biological medicines.
In three different late-stage studies, the company has achieved all primary and secondary effect goals, which is a result that research director Kim Kjøller calls ”incredibly strong”. Leo Pharma is now counting on using this data as a basis for approval applications to health authorities controlling the large markets in the new year.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Zealand Pharma sells shares for over USD 100m
With a 5% discount, the biotech company managed to sell 4,975,000 of its own shares in a direct issuance.
Zealand Pharma CEO: Share sale arms us for partnership negotiations
After a study success with short bowel syndrome treatment candidate, the Danish biotech company raised funding by issuing shares, preparing the company’s CEO, Adam Steensberg, to enter dialogs with a number of potential partners.
Complete company divestment is not part of Zealand Pharma's strategy
After a Nordnet analyst brought up the possibility of the Danish company being an acquisition target for foreign firms, CEO Adam Steensberg has ruled out the notion of a full sale.
Three scientists share chemistry Nobel for cancer improvement technology breakthrough
Danish national Morten Meldal and two colleagues have been awarded the prestigious award for their research into click chemistry, which is used the development of cancer drugs.
Audientes builds on Q2 momentum, maintains guidance
The hearing aid company has sold self-fitting hearing aids for over DKK 2m (USD 266,700) during the third quarter that ended in September.
Senior CMC Regulatory Manager 
Lab Manager 
Product specialist 
Pharmacovigliance (Associate) Director or Senior Specialist 
Head of department RA/QA/PV, Danmark 
CMC Writer 
Nordic Key Account Manager, Hollister & Dansac 
Manager for Process Support - 1st line support 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Clinical Project Lead 
Scientist Radiochemistry